+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Epirubicin Market by Product (Anthracyclines, Chromomycins), Dosage (100Mg/Vial, 10Mg/Vial, 200Mg/Vial), Applications, Distribution Channel - Forecast 2024-2030- Product Image
Global Epirubicin Market by Product (Anthracyclines, Chromomycins), Dosage (100Mg/Vial, 10Mg/Vial, 200Mg/Vial), Applications, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Epirubicin Market by Product (Anthracyclines, Chromomycins), Dosage (100Mg/Vial, 10Mg/Vial, 200Mg/Vial), Applications, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967872
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Epirubicin Market size was estimated at USD 224.16 million in 2023, USD 234.83 million in 2024, and is expected to grow at a CAGR of 4.91% to reach USD 313.74 million by 2030.

Epirubicin is a chemotherapy medication used primarily to treat breast cancer and is also employed in the treatment of other cancers, such as stomach and lung cancers. It falls under anthracyclines, which interfere with the DNA inside cancer cells, preventing their growth and multiplication. Increasing incidences of cancer worldwide are raising the need for epirubicin. As more people are diagnosed with cancer, the demand for effective treatment options, including chemotherapy drugs and epirubicin, rises. Expanding healthcare infrastructure, particularly in developing countries, increases access to cancer treatments and supports the growth of chemotherapy drugs such as epirubicin.

Side effects and availability of alternatives associated with epirubicin hamper the market growth. Rising research & development activities lead to better understanding and enhancements in drug formulations, which can expand the use of epirubicin and are expected to create opportunities for market growth. Improvements in drug delivery systems and reduction of side effects can make it a more appealing option for oncologists and patients.

Regional Insights

In the Americas, there is a high level of awareness about breast cancer and access to healthcare services, which drives need for epirubicin. The Americas holds a significant share of the market due to established healthcare infrastructure and ongoing research in oncology treatments. In South America, the market is growing as healthcare systems improve and there is increased access to cancer treatment. The Asia-Pacific region is witnessing rapid growth in the epirubicin market due to increasing healthcare expenditure and the rising incidence of cancer. Countries inclduing, China and India are key countries because of their large populations and improving healthcare facilities.

In Europe, the market is highly developing with well-established healthcare systems and guidelines for cancer treatment which support the use of epirubicin. Western European countries such as Germany, France, and the UK lead in consumption due to better healthcare infrastructure and higher spending on oncology. The Middle East and Africa are experiencing growth due to increasing awareness of cancer treatments and gradual improvements in healthcare facilities.

Market Trends by Segment

  • Product: Growing usage of anthracyclines to stop the growth of cancer
  • Applications: High potential of epirubicin for reducing the recurrence of superficial bladder cancers

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Pioneering Health Innovations: ARPA-H's Strategic Funding Bolsters Biden Cancer Moonshot

U.S. Department of Health and Human Services' Advanced Research Projects Agency for Health (ARPA-H) unveiled its allocation of over USD 330 million for new research projects aimed at catalyzing significant biomedical breakthroughs. These projects, integral to advancing the objectives of President Biden's Cancer Moonshot and Unity Agenda, focus on enhancing healthcare research, treatment, and outcomes nationwide. ARPA-H's investments aim to develop groundbreaking technologies and solutions across crucial medical fields, including cancer treatment, organ transplantation, combating superbugs, and bolstering human immunity, ensuring broad-reaching impacts on public health and healthcare efficiency.

Key Company Profiles

The report delves into recent significant developments in the Epirubicin Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Baxter International Inc., Celgene Corporation, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Eisai Co., Ltd., Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Mylan N.V., Novartis AG, Pfizer, Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

This research report offers invaluable insights into various crucial aspects of the Epirubicin Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer cases worldwide
5.1.1.2. Increasing government investments to expand cancer research activities worldwide
5.1.2. Restraints
5.1.2.1. Development of drug resistance associated with epirubicin
5.1.3. Opportunities
5.1.3.1. Growing research & development activities associated with drug formulations and the use of epirubicin
5.1.3.2. Expanding investments in healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Availability of alternative therapeutic technologies
5.2. Market Segmentation Analysis
5.2.1. Product: Growing usage of anthracyclines to stop the growth of cancer
5.2.2. Applications: High potential of epirubicin for reducing the recurrence of superficial bladder cancers
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Epirubicin Market, by Product
6.1. Introduction
6.2. Anthracyclines
6.3. Chromomycins
7. Epirubicin Market, by Dosage
7.1. Introduction
7.2. 100Mg/Vial
7.3. 10Mg/Vial
7.4. 200Mg/Vial
7.5. 50Mg/Vial
8. Epirubicin Market, by Applications
8.1. Introduction
8.2. Bladder Cancer
8.3. Breast Cancer
8.4. Liver Cancer
9. Epirubicin Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Epirubicin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Epirubicin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Epirubicin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Pioneering Health Innovations: ARPA-H's Strategic Funding Bolsters Biden Cancer Moonshot
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. EPIRUBICIN MARKET RESEARCH PROCESS
FIGURE 2. EPIRUBICIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL EPIRUBICIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL EPIRUBICIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL EPIRUBICIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EPIRUBICIN MARKET DYNAMICS
FIGURE 7. GLOBAL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EPIRUBICIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EPIRUBICIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EPIRUBICIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. EPIRUBICIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. EPIRUBICIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL EPIRUBICIN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL EPIRUBICIN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL EPIRUBICIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL EPIRUBICIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL EPIRUBICIN MARKET SIZE, BY ANTHRACYCLINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL EPIRUBICIN MARKET SIZE, BY ANTHRACYCLINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL EPIRUBICIN MARKET SIZE, BY CHROMOMYCINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL EPIRUBICIN MARKET SIZE, BY CHROMOMYCINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL EPIRUBICIN MARKET SIZE, BY 100MG/VIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL EPIRUBICIN MARKET SIZE, BY 100MG/VIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL EPIRUBICIN MARKET SIZE, BY 10MG/VIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL EPIRUBICIN MARKET SIZE, BY 10MG/VIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL EPIRUBICIN MARKET SIZE, BY 200MG/VIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL EPIRUBICIN MARKET SIZE, BY 200MG/VIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL EPIRUBICIN MARKET SIZE, BY 50MG/VIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL EPIRUBICIN MARKET SIZE, BY 50MG/VIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL EPIRUBICIN MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL EPIRUBICIN MARKET SIZE, BY BLADDER CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL EPIRUBICIN MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL EPIRUBICIN MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL EPIRUBICIN MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL EPIRUBICIN MARKET SIZE, BY LIVER CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL EPIRUBICIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL EPIRUBICIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL EPIRUBICIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL EPIRUBICIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL EPIRUBICIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL EPIRUBICIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS EPIRUBICIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS EPIRUBICIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 65. CANADA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. CANADA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. CANADA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 68. CANADA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 69. CANADA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 70. CANADA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 71. CANADA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. CANADA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. MEXICO EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. MEXICO EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. MEXICO EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 76. MEXICO EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 77. MEXICO EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 78. MEXICO EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 79. MEXICO EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. MEXICO EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES EPIRUBICIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES EPIRUBICIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC EPIRUBICIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. CHINA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. CHINA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. CHINA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 112. CHINA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 113. CHINA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 114. CHINA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 115. CHINA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. CHINA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. INDIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. INDIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. INDIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 120. INDIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 121. INDIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 122. INDIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 123. INDIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. INDIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. JAPAN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. JAPAN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. JAPAN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 136. JAPAN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 137. JAPAN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 138. JAPAN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 139. JAPAN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. JAPAN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 181. THAILAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. THAILAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. THAILAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 184. THAILAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 185. THAILAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 186. THAILAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 187. THAILAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. THAILAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA EPIRUBICIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 207. DENMARK EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. DENMARK EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. DENMARK EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 210. DENMARK EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 211. DENMARK EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 212. DENMARK EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 213. DENMARK EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. DENMARK EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. EGYPT EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. EGYPT EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. EGYPT EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 218. EGYPT EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 219. EGYPT EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 220. EGYPT EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 221. EGYPT EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 222. EGYPT EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 223. FINLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. FINLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. FINLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 226. FINLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 227. FINLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 228. FINLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 229. FINLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. FINLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. FRANCE EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. FRANCE EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. FRANCE EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 234. FRANCE EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 235. FRANCE EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 236. FRANCE EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 237. FRANCE EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. FRANCE EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. GERMANY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. GERMANY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. GERMANY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 242. GERMANY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 243. GERMANY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 244. GERMANY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 245. GERMANY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 246. GERMANY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. ITALY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. ITALY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. ITALY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 258. ITALY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 259. ITALY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 260. ITALY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 261. ITALY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. ITALY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. NORWAY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. NORWAY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. NORWAY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 282. NORWAY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 283. NORWAY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 284. NORWAY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 285. NORWAY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 286. NORWAY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 287. POLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. POLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. POLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 290. POLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 291. POLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 292. POLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 293. POLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 294. POLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 295. QATAR EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. QATAR EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. QATAR EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 298. QATAR EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 299. QATAR EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 300. QATAR EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 301. QATAR EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 302. QATAR EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 327. SPAIN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. SPAIN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. SPAIN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 330. SPAIN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 331. SPAIN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 332. SPAIN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 333. SPAIN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 334. SPAIN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 351. TURKEY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. TURKEY EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. TURKEY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 354. TURKEY EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 355. TURKEY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 356. TURKEY EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 357. TURKEY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 358. TURKEY EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 368. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 369. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 370. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 371. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 372. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 373. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 374. UNITED KINGDOM EPIRUBICIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 375. EPIRUBICIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 376. EPIRUBICIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • AstraZeneca PLC
  • Baxter International Inc.
  • Celgene Corporation
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eisai Co., Ltd.
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 234.83 Million
Forecasted Market Value ( USD ) by 2030 $ 313.74 Million
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Anthracycline Global Market Report 2024 - Product Image

Anthracycline Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Esophageal Cancer Global Market Report 2024 - Product Image

Esophageal Cancer Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Hedgehog Pathway Inhibitors Market by Generic Drug Name (Glasdegib, Sonidegib, Vismodegib), Dosage (Capsule, Injection), Distribution Channel, Cancer Indication, End-Users - Forecast 2024-2030 - Product Image

Global Hedgehog Pathway Inhibitors Market by Generic Drug Name (Glasdegib, Sonidegib, Vismodegib), Dosage (Capsule, Injection), Distribution Channel, Cancer Indication, End-Users - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global CD40 Ligand Market by Type (Monoclonal Antibody, Polyclonal Antibody), Application (Autoimmune Disease Treatment, Immunotherapy, Vaccine Development), End-Users - Forecast 2024-2030 - Product Image

Global CD40 Ligand Market by Type (Monoclonal Antibody, Polyclonal Antibody), Application (Autoimmune Disease Treatment, Immunotherapy, Vaccine Development), End-Users - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
FYARRO Market Size, Forecast, and Market Insight - 2032 - Product Image

FYARRO Market Size, Forecast, and Market Insight - 2032

  • Report
  • 30 Pages
  • Global
From

About the Epirubicin Market

Epirubicin is an oncology drug used to treat a variety of cancers, including breast, ovarian, and bladder cancer. It is a type of anthracycline, a class of chemotherapy drugs that work by interfering with the growth of cancer cells. Epirubicin is administered intravenously and is often used in combination with other chemotherapy drugs. It is also used in the treatment of metastatic cancer, which is cancer that has spread to other parts of the body. Epirubicin is generally well tolerated, but can cause side effects such as nausea, vomiting, hair loss, and fatigue. It can also cause damage to the heart, so it is important to monitor patients closely for any signs of cardiac toxicity. The epirubicin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Novartis, Teva Pharmaceuticals, and Mylan. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.